The global cardiac surgery devices market size was valued at USD 3.01 billion in 2025 and is projected to grow from USD 3.24 billion in 2026 to USD 5.76 billion by 2034, registering a CAGR of 7.48% during the forecast period (2026-2034). North America dominated the cardiac surgery devices market with a share of 46.37% in 2025.
Cardiac surgery devices are medical instruments and equipment used to support surgical procedures involving the heart and cardiovascular system. Cardiac surgery devices are commonly classified under HSN Code 9018 (instruments and appliances used in medical, surgical, dental, or veterinary sciences) and SIC Code 3841 (Surgical and Medical Instruments and Apparatus).
The cardiac surgery devices market demand is driven by the growing prevalence of cardiovascular diseases and the adoption of minimally invasive techniques. Healthcare providers are increasingly using heart valve devices, cardiac ablation devices, surgical staplers, cardiac catheters, and cardiac implants to support precise and efficient cardiac procedures, contributing to cardiac surgery devices market growth.
By Product
By Application
By End Use
Download a Free Sample To learn more about this report,
Shift toward Minimally Invasive Cardiac Surgery Devices
The cardiac surgery devices market analysis shows a shift toward minimally invasive cardiac surgery devices that enable cardiac procedures through smaller incisions and reduced surgical access. These devices are designed to support procedures with less tissue disruption compared with conventional open surgery. This development supports shorter recovery periods and reduced postoperative complications.
Integration of Advanced Imaging with Cardiac Surgery Devices
The cardiac surgery devices market is witnessing greater integration of advanced imaging with cardiac surgery devices to provide detailed visualization of cardiac structures during surgical procedures. Technologies such as three-dimensional imaging, intraoperative ultrasound, and image-guided navigation can support surgical planning and device positioning.
Supply chain disruptions are expected to have a high impact on the cardiac surgery devices market share due to dependence on surgical instruments, cardiac implants, catheters, surgical staplers, imaging components, and specialized medical device manufacturing networks. The market is expected to follow a stair-step recovery, as shortages of medical device components, manufacturing delays, sterilization constraints, and transportation disruptions can affect device availability and hospital procurement in phases before component supplies and production capacity stabilize. The market is expected to grow at a CAGR of 7.48%, but supply chain constraints could approximately lower this by 1.0 percentage point, resulting in short-term growth of around 6.48%. As supply conditions normalize through improved availability of surgical components and cardiac devices, stable manufacturing capacity, smoother sterilization processes, and improved healthcare logistics, cardiac surgery devices market growth is expected to gradually return to 7.48%.
The cardiac surgery devices market forecasts strategic investment activity driven by robotic-assisted surgery platforms, minimally invasive cardiac procedures, advanced cardiovascular surgical instruments, and cardiac ablation systems.
Medtronic
USD 700 Million
In September 2026, Medtronic announced an approximately USD 700 million strategic investment in Cornerstone Robotics to expand access to robotic-assisted surgery and strengthen its global minimally invasive surgery portfolio.
Medinice
USD 16 Million+
In April 2026, Medinice secured more than PLN 58 million, approximately USD 16 million, from a Polish pension fund to support development of minimally invasive cardiac surgery and pulsed field ablation technologies.
Demand for Advanced Heart Valve Repair Devices and Use of Disposable Cardiac Surgery Devices Drives Market
The demand for advanced heart valve repair devices is driving the cardiac surgery devices market as clinicians increasingly adopt less-invasive technologies for treating structural heart conditions. Transcatheter systems such as the PASCAL Precision and TriClip G4 provide repair options without open-heart surgery, supporting demand for specialized delivery systems, implants, and cardiac intervention devices.
The use of disposable cardiac surgery devices is supporting market demand as hospitals require sterile, procedure-specific equipment for cardiac interventions while limiting cross-patient contamination risks. Single-use devices such as access systems and catheter-based surgical accessories are increasingly incorporated into minimally invasive cardiac procedures, supporting demand for disposable surgical components and delivery systems. The US FDA and CMS identify sterile, single-use cardiac procedure devices within their medical device and reimbursement frameworks.
Risk of Complications and Complexity of Using Advanced Cardiac Surgery Devices Restrain Market Expansion
The risk of complications associated with cardiac surgery devices can limit their adoption in clinical settings. Device use during complex cardiac procedures may involve risks such as bleeding, infection, tissue damage, or devicerelated complications. These risks can require additional monitoring and intervention during or after surgery.
The complexity of using advanced cardiac surgery devices can create challenges for healthcare providers during cardiac procedures. Advanced devices may require specialized training, precise handling, and familiarity with complex surgical techniques. These factors can slow adoption of advanced cardiac surgery devices and restrain market expansion.
Expansion of Cardiac Surgery Devices in Valve Replacement and Postoperative Patient Monitoring Offers Growth Opportunities to Market Players
The need to treat heart valve disorders is creating opportunities for cardiac device manufacturers to serve hospitals, cardiac centers, and surgeons. Advanced surgical devices can support valve repair and replacement procedures for patients with complex heart conditions. Revenue can be generated through device sales, procedure-specific instruments, and hospital supply contracts, contributing to the cardiac surgery devices market growth.
The increasing focus on patient recovery after cardiac procedures is creating opportunities for medical device providers to serve hospitals and specialized cardiac care centers. Monitoring devices can support the assessment of vital parameters and recovery during the postoperative period.
The heart valve segment accounted for a share of 19.38% in 2025 due to the widespread use of valve repair and replacement procedures for managing structural heart surgery.
The cardiac ablation devices segment is expected to grow at a CAGR of 8.92% during the forecast period, driven by the use of ablation procedures for treating cardiac arrhythmias.
Request Customizationto receive a tailored report.
The coronary artery bypass grafting (CABG) segment accounted for a share of 31.26% in 2025, owing to the continued use of bypass procedures for patients with significant coronary artery disease.
The heart valve surgery segment is expected to grow at a CAGR of 8.12% during the forecast period, fueled by increasing prevalence of valvular heart diseases and continued adoption of advanced valve repair and replacement techniques.
The hospitals segment accounted for a share of 62.48% in 2025, supported by the availability of specialized cardiac surgery departments, operating rooms, intensive care facilities, and trained surgical teams.
The ambulatory surgical centers segment is expected to grow at a CAGR of 8.46% during the forecast period, propelled by the adoption of selected cardiac procedures in specialized outpatient settings.
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by Adoption of Cardiopulmonary Bypass Systems and Perfusion Equipment
The North America cardiac surgery devices market accounted for a share of 46.37% in 2025.
The U.S. cardiac surgery devices market is supported by continued use of cardiopulmonary bypass and heart lung machines in complex cardiac procedures. The U.S. Food and Drug Administration classifies cardiopulmonary bypass heart lung machine consoles as regulated cardiovascular devices, with approved systems supporting extracorporeal circulation during cardiac surgery.
The Canada cardiac surgery devices market is shaped by the adoption of cardiopulmonary bypass systems and perfusion equipment. Cardiac surgery programs in provinces such as Ontario and Quebec use cardiopulmonary bypass systems, oxygenators, and perfusion disposables for adult and pediatric cardiac procedures, supporting continued demand for these devices.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Fastest Growth Driven by Robotic Surgery and Domestic Medical Device Manufacturing Base
The Asia Pacific cardiac surgery devices market is expected to grow at a CAGR of 9.31% during the forecast period, making it the fastest-growing region.
The China cardiac surgery devices market benefits from the demand for cardiac catheters and surgical devices. The products from Abbott, Medtronic, and Boston Scientific were selected in China's national coronary stent procurement renewal, reflecting continued demand for catheter based coronary intervention devices.
The India cardiac surgery devices market is expected to benefit from the expansion of cardiac surgery infrastructure and increasing adoption of advanced cardiovascular devices. In 2026, AIIMS Guwahati commenced its cardiac surgery program, while AIIMS Raipur expanded complex pediatric cardiac surgery capabilities, strengthening access to specialized procedures. Government initiatives supporting domestic medical device manufacturing have also enabled production of heart valves and stents, supporting broader availability of cardiac surgery devices in India.
Japan’s National Cerebral and Cardiovascular Center provides minimally invasive cardiac surgery, robotic surgery, transcatheter valve replacement, complex valve repair, and mechanical circulatory support. The Ministry of Health, Labour and Welfare continues to expand insurance coverage for medical devices through regular reimbursement updates. These developments are expected to support demand for cardiac valves, heart-lung systems, circulatory support devices, surgical instruments, and other advanced cardiac surgery technologies.
Europe: Market Expansion Fueled by Coronary Artery Bypass Graft Adoption and Advanced Heart Valve Centers
The Europe cardiac surgery devices market is expected to grow at a CAGR of 6.84% during the forecast period.
The UK cardiac surgery devices market is shaped by the continued demand for Coronary Artery Bypass Graft (CABG) and valve replacement procedures. NHS England’s National Adult Cardiac Surgery Audit continues to track CABG and heart valve surgery outcomes across cardiac surgery centers, supporting ongoing monitoring and development of cardiac surgical services.
The Germany cardiac surgery devices market is expected to benefit from the continued adoption of minimally invasive and robotic cardiac procedures. The German Heart Center Berlin has operated robot-assisted mitral valve procedures since early 2025, while the Leipzig Heart Center is also expanding the use of robotic systems for minimally invasive cardiac surgery. Germany’s advanced heart valve centers also perform large volumes of transcatheter procedures such as TAVI, supporting demand for surgical instruments, heart valves, robotic systems, and other cardiac surgery devices.
Latin America: Market Growth Driven by Established Clinical Guidelines
The Latin America cardiac surgery devices market is expected to grow at a CAGR of 7.76% during the forecast period. Brazilian clinical guidelines recognize mechanical circulatory support devices for patients with advanced systolic heart failure, including their use as a bridge to transplantation and as long term therapy in selected patients.
Mexico’s national hospital infrastructure plan includes 152 hospital projects through 2030. The Instituto Mexicano del Seguro Social (IMSS) has expanded cardiac care capacity through upgraded operating rooms, postoperative intensive care areas, and hemodynamic facilities. The adoption of advanced procedures such as transcatheter aortic valve implantation and minimally invasive valve repair also supports the demand for heart valves, surgical instruments, catheter-based systems, and other cardiac surgery devices.
Middle East & Africa: Market Expansion Led by Adoption of Operating Room Equipment
The Middle East & Africa cardiac surgery devices market is expected to grow at a CAGR of 7.39% during the forecast period. In the UAE, Burjeel Hospital Abu Dhabi and Burjeel Specialty Hospital Sharjah introduced AI-powered cardiac catheterization laboratories featuring advanced imaging, 3D visualization, and automated workflows for complex cardiovascular procedures.
In 2026, the Free State opened a digitally enabled paediatric cardiology catheterisation laboratory at Universitas Academic Hospital and began commissioning adult cardiac catheterisation facilities. Charlotte Maxeke Johannesburg Academic Hospital has introduced MitraClip therapy for high-risk mitral regurgitation patients. These developments are expected to support demand for heart valves, catheter-based systems, surgical instruments, cardiac monitoring equipment, and other advanced cardiac surgery devices in South Africa.
The cardiac surgery devices market competitive landscape is highly fragmented, with established medical device manufacturers, cardiovascular technology companies, cardiac surgery equipment providers, and specialized cardiac care solution providers. Key players such as Medtronic plc, Abbott Laboratories, Edwards Lifesciences Corporation, Getinge AB, and LivaNova PLC are estimated to account for approximately 35–40% of the global cardiac surgery devices market share.
Established players compete mainly through cardiac device innovation, minimally invasive technologies, cardiovascular implants, clinical research capabilities, and global distribution networks. Emerging and regional players in the cardiac surgery devices market ecosystem focus on specialized cardiac devices, competitive pricing, localized services, and application-specific cardiovascular technologies.
April 2026: Medtronic launched the Mosaic Neo mitral bioprosthesis in the U.S. following FDA approval, supporting sternotomy, minimally invasive cardiac surgery, and robotic procedures.
May 2026: Abbott introduced the TriClip transcatheter edge to edge repair system in India, providing a minimally invasive option for patients with tricuspid regurgitation.
Customize This Report to Match Your Strategic Objectives
Author's Details
Research Experts
The Straits Research Team is a group of experienced researchers, analysts, and industry professionals dedicated to delivering reliable, insightful, and well-structured market intelligence. With expertise across multiple sectors and domains, the team combines extensive research, data analysis, and industry knowledge to provide a clear understanding of evolving markets and business environments.
The team focuses on identifying key market trends, emerging opportunities, technological developments, competitive landscapes, and changing industry dynamics. Through a thoughtful and research-driven approach, it aims to provide valuable insights that help businesses, investors, and decision-makers better understand their industries and make informed strategic decisions.
Respirators Market Size, Share, Growth, Analysis, Report, 2034
Interventional Radiology Market Size, Share, Growth, Analysis, 2034
Dental Intraoral Scanners Market Size, Share, Growth, 2034
Germany Surgical Equipment Market Size, Share and Forecast to 2034
Europe Surgical Equipment Market Size, Top Share and Forecast to 2034
Biofeedback Instrument Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com